Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia
- 1 January 2004
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 148 (1), 71-76
- https://doi.org/10.1016/s0165-4608(03)00233-4
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Hypodiploidy is a major prognostic factor in multiple myelomaBlood, 2001
- Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myelomaBritish Journal of Haematology, 2001
- The biology of multiple myelomaZeitschrift für Krebsforschung und Klinische Onkologie, 2000
- Clinical Significance of the Translocation (11;14)(q13;q32) in Multiple MyelomaLeukemia & Lymphoma, 1999
- Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 casesBritish Journal of Haematology, 1998
- Prognostic value of cytogenetics in multiple myelomaBritish Journal of Haematology, 1998
- Multiple Myeloma: Increasing Evidence for a Multistep Transformation ProcessBlood, 1998
- Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myelomaBritish Journal of Haematology, 1997
- Karyotype in multiple myeloma and plasma cell leukaemiaEuropean Journal Of Cancer, 1993
- The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosisBlood, 1985